LYNN A. TETRAULT - Corporate Board Profile

NEOGENOMICS INC

Filing Date	Source Excerpt
2015-05-19	Lynn A. Tetrault, age 52. Mrs. Tetrault will be new to the board of directors. ... The Board has determined that each of Mrs. Tetrault ... is independent. ... The Board currently has four (4) standing committees: the Audit Committee, the Nominating and Corporate Governance, the Compensation Committee and the Compliance Committee. ... The following table sets forth the current members of each standing Committee: ... Lynn A. Tetrault ... Nominating and Corporate Governance Committee ... The following table provides information concerning the compensation of our non-employee directors for the year ended December 31, 2014. ... No compensation listed for Mrs. Tetrault.
2016-04-29	Lynn A. Tetrault, age 53. Mrs. Tetrault has served as a director since June 2015. ... Director Compensation ... Lynn A. Tetrault ... Total ($) 69,217
2017-04-25	Lynn A. Tetrault, age 54. Mrs. Tetrault has served as a director since June 2015. ... Lynn A. Tetrault, Board Member and Chairwoman of the Compensation Committee. ... The following table sets forth the current members of each standing Committee: ... Lynn A. Tetrault Audit Committee, Compensation Committee (Chair). ... Director Compensation ... Lynn A. Tetrault 70,000 Fees earned in cash, 61,307 Stock Awards, 26,390 Warrant/Option Awards, Total 157,697.
2018-04-20	Lynn A. Tetrault, age 55. Ms. Tetrault has served as a director since June 2015. ... Lynn Tetrault is a dynamic, seasoned executive in the pharmaceutical industry. ... Ms. Tetrault’s experience will help shape human resource policies and operations as well as the make-up of the board of directors and its governance policies.
2019-04-22	Lynn A. Tetrault, age 56. Ms. Tetrault has served as a director since June 2015. She is Chairwoman of the Compensation Committee. Director compensation table shows Lynn A. Tetrault total compensation as $161,289.
2020-04-15	Lynn A. Tetrault, age 57. Ms. Tetrault has served as a director since June 2015. Ms. Tetrault is founder and principal of Anahata Leadership, an advisory firm focused on supporting the leadership effectiveness and development of executive women.
2021-04-15	Lynn A. Tetrault, age 58. Ms. Tetrault has served as a director since June 2015 and was appointed Lead Independent Director of the Company in July 2020. She also serves as a non-executive director of Rhythm Pharmaceuticals, Inc., a position to which she was appointed in December 2020.
2022-04-14	Lynn A. Tetrault, age 59, Executive Chair of the Board. Ms. Tetrault was appointed Executive Chair of the Board effective March 28, 2022. Prior to that time, Ms. Tetrault served as non-executive Chair since October 2021, as Lead Independent Director of the Company from July 2020 to October 2021 and as a director since June 2015. ... The Board has the discretion to grant equity awards to independent directors as part of their compensation. Board members receive total annual equity compensation having a grant date fair value of $180,000. On June 2, 2021, each independent director, with the exception of Mr. Daly, was granted 3,081 shares of restricted stock and 3,714 stock option awards. ... The following table provides information concerning the compensation of our non-employee directors for the year ended December 31, 2021. ... Lynn A. Tetrault 97,668 Fees Earned or Paid in Cash, 161,000 Stock Awards, 69,000 Option Awards, Total 327,668.
2025-04-08	Lynn A. Tetrault (non-executive Chair of the Board) - Ms. Tetrault has served as the non-executive Chair of the Board since August 2022. Ms. Tetrault has been a director since June 2015. For service as a director during 2024, independent directors received total annual equity compensation having a grant date fair value of $240,000. The independent director appointed as Chair of the Board received additional annual compensation of $62,500. Ms. Tetrault received total compensation of $370,100 in 2024. She serves on the Culture and Compensation Committee, Compliance Committee, and Nominating and Corporate Governance Committee.